Current issue #20, 2015

Imperial ambitions

Distributor will cease working with pharmacies and will focus on state procurement

In early June, Imperia-Pharma, a St. Petersburg-based pharmaceutical distributor surprised the market with the news on bankruptcy. It turned out later that it was only Imperia-Pharma’s subsidiary that was being liquidated, and the bankruptcy claim was submitted by ProfSoyuz affiliated with Imperia-Pharma. The first court hearing was held on 15^th of June. The distributor remains on the market; however, it will no longer work with pharmaceutical retailers and will focus on state procurement. To this end, it already has a separate entity called Grama. Experts are sure that Imperia-Pharma’s withdrawal from the commercial market is not related with the economic crisis.

[PharmVestnik # 20, 23/06/2015, p. 1, cont’d p. 3]

A spoke in wheel

Manufacturers of dietary supplements disagree with inspection findings

In early June, a press conference on counterfeit drug turnover was held. It was devoted to the earlier published (for details see the material “Knock-out dose”, PharmVestnik No. 18 dated 02.06.2015) deplorable results of studying the dietary supplements pharmacy segment: in the composition of the most popular dietary supplements boosting sexual vigor, Rx drug ingredients were detected. However, PharmVestnik was contacted by representatives of the accused party, i.e. manufacturers of dietary supplements. They claim that the information on the presence of Rx drug ingredients in their products is inaccurate.

[PharmVestnik # 20, 23/06/2015, p. 2]

Limping in tune with the times

Ministry of Health offers to equip villages with Skype and improves functionality of its website

Ministry of Health image spending and ideas for promoting web technologies to the patients excite the public. Published results of the bidding for updating the Ministry’s official website together with the Health Minister’s announcement of а new medical service for inhabitants of remote villages — doctor’s advice by Skype — taking place against the background of a regular inspection of the Ministry by the Auditing Chamber do not encourage optimism and make some experts doubt the adequacy of the things going on.

[PharmVestnik # 20, 23/06/2015, p. 1, cont'd p. 4]

Specifics of national vaccination

Rostech Group reviews its biopharmaceutical assets

As it has become known to PharmVestnik, biopharmaceutical company FORT passed an independent technological audit of its manufacturing site. The auditor wa...